GCG and diabetes mellitus: Data from preclinical and clinical studies suggest that long-term GLP-1 treatment protects the macrovasculature in diabetes, evidenced by reduced inflammatory signaling in macrophages, improved plasma lipid profiles, and reduced blood pressure [10–12].